Zenotech Laboratories Ltd
BSE:532039
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
56.47
101.67
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Zenotech Laboratories Ltd
Cost of Revenue
Zenotech Laboratories Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Cost of Revenue
-â‚ą2.1m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
15%
|
CAGR 10-Years
31%
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Cost of Revenue
-â‚ą218.1m
|
CAGR 3-Years
37%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
||
Transgene Biotek Ltd
BSE:526139
|
Cost of Revenue
-â‚ą4k
|
CAGR 3-Years
81%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
||
Hester Biosciences Ltd
NSE:HESTERBIO
|
Cost of Revenue
-â‚ą901.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
||
Biocon Ltd
NSE:BIOCON
|
Cost of Revenue
-â‚ą49.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-15%
|
||
Panacea Biotec Ltd
NSE:PANACEABIO
|
Cost of Revenue
-â‚ą2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
Zenotech Laboratories Ltd
Glance View
Zenotech Laboratories Ltd. engages in the manufacture and marketing of pharmaceuticals products. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the business of manufacturing and marketing biotechnology and pharmaceuticals products. The Company’s injectables product portfolio primarily serves niche therapy areas, such as oncology and anesthesiology. The firm has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
See Also
What is Zenotech Laboratories Ltd's Cost of Revenue?
Cost of Revenue
-2.1m
INR
Based on the financial report for Sep 30, 2024, Zenotech Laboratories Ltd's Cost of Revenue amounts to -2.1m INR.
What is Zenotech Laboratories Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
31%
The average annual Cost of Revenue growth rates for Zenotech Laboratories Ltd have been -129% over the past three years , 15% over the past five years , and 31% over the past ten years .